Matthew Rosenberger

Nexmedia Technologies, Inc. develops e-commerce solutions.

Expresso Fitness Corp. develops and manufactures cardio fitness systems. Its customers include YMCA, Crunch, Healthtrax, and Club Sport. The firm manufactures fitness bicycles that incorporate interactive and virtural reality programs. The company was founded in 2003 and is headquartered in Sunnyvale, CA.

HS Winddown, Inc. engages in provision of clean water technology, that provides solutions to the growing issue of water stress. It focuses on providing cleaner, clearer, safer water using its proprietary platforms of N-halamine polymers to purify drinking water, killing bacteria and viruses that may cause diseases. The company was founded on March 18, 1997 and is headquartered in Mukilteo, WA.

Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.

RBC Capital Partners Ltd. is a Venture Capital firm, a subsidiary of RBC Dominion Securities, Inc. founded in 1900. RBC Capital Partners Ltd. is headquartered in Toronto, Canada with offices across the globe.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada.

Pharmaca Integrative Pharmacy, Inc. operates as a pharmacy and health store. Its products includes facial care and makeup products, as well as beauty accessories; body care, hair care, bath and shower, sun care and bug spray, shaving and hair removal, hand and foot care, and kids and baby skin care and bath products; vitamins, supplements, minerals, sports and nutrition. The firm has offices in California, New Mexico, Oregon, and Washington. The company was founded by Don L. Summerfield, Dale Schwartz and Barry Perzow in June 2000 and is headquartered in Boulder, CO.

Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada.

Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada.

LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada.

Physic Ventures LLC (Physic Ventures) is a venture capital firm founded in 2006 by Dion Madsen and Will B. Rosenzweig. The firm is headquartered in San Francisco, California.

Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada.

BioTalent Canada is a non-profit organization, which focuses on building partnerships and skills for Canada?s bio-economy to ensure the industry has access to job-ready people. It connects employers with job seekers, delivers human resource information, and skills development tools so the biotech industry through projects, research and product development .The company is headquartered in Ottawa, Canada.

Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada.

Phemi SystemsCorp., operates as a big data warehouse company. It serves to healthcare institutions. The firm’s products include PHEMI central and PHEMI clinical. The company was founded by Alan Rabinowitz, Paul Terry, Adam Lorant, and John M. Seminerio in 2013 and is headquartered in Vancouver, Canada.

Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann.

Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada.

Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands.

ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland.

Surgical Safety Technologies, Inc. improves surgical performance and safety while reducing healthcare costs. The company is based in Toronto, Canada. The Canadian company was founded by Teodor Grantcharov.

Chinook Therapeutics U.S., Inc. operates as a development stage company. The company is headquartered in Seattle, WA.

Xap Therapeutics Ltd is a British company that specializes in developing tailor-made therapies for the treatment of complex diseases such as cancer and autoimmunity. Xap Therapeutics is based in Cambridge, UK and was founded in 2017 by Shaun Patrick Foy and James Patterson. The company takes inspiration from the principle of exaptation and uses the power of genome editing and synthetic biology to convert nature's ultimate first-responder cell into a modular chassis, ready to be programmed to treat disease. The company's interdisciplinary team of exceptional scientists is key to its success.

Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021.

Ability Biologics, Inc. develops and manufactures immune modulating biotherapeutics and human therapeutic ready antibodies. The company is based in Montréal, Canada. It was founded by Giles Day and Jean-Philippe Bürckert, with Giles Day serving as the CEO since incorporation.